ToolsThe story, in brief

How a Gemma model helped discover a new potential cancer therapy pathway

Not a chatbot. Google's new 27B Gemma model just helped identify a novel cancer therapy pathway—AI moving from demos to real biotech breakthroughs.

Illustration of a transparent lens revealing connected networks across layers of paper.
Exploring the next frontier of AI research.AI illustration by KeyNews
The KeyNews take

Why it matters

Google is shipping a specialized foundation model for single-cell biology built on Gemma, demonstrating AI's application beyond consumer chatbots into high-stakes drug discovery. This signals the shift toward vertical, domain-specific model releases that solve real research problems.

The key facts

6 to know
  1. 27 billion parameter foundation model

  2. Built on Gemma family

  3. Single-cell analysis focus

  4. Cancer therapy pathway discovery use case

  5. October 2025 launch

  6. Open model approach (Gemma is open-source)

Go to the source

Google DeepMind Blogdeepmind.google

Publisher excerpt: We’re launching a new 27 billion parameter foundation model for single-cell analysis built on the Gemma family of open models.
Read original report
Back to today's editionMore tools news

Keep reading

Related stories

More from Tools